News Article
The whole business sector has responded to the crisis, supporting communities and healthcare staff.
While the world waits on the next big cure or treatment in medicine, pioneers in the field are working to deliver just that.
Analysis
“Over the next few years we will be looking into biosimilars, a growing niche believed to be the future of the pharmaceutical industry”
View from the Top
Elvin Penn
Director General
Amgen
We have been present in Mexico since 2006 with our R&D operations and we started commercializing our products in 200
View from the Top
Elvin Penn
Director General
Amgen
Amgen has nine biosimilars in development, with the first expected to come to market in 2017.
Analysis
Biotechnology companies are powerful players in the pharmaceutical sector due to the strong link between biotechnology and drug discovery process.